PRESS RELEASE

[News] Bioplus signs contracts with Orabio for joint development of next-generation Botox

By 2021년 May 17일July 23rd, 2021No Comments

Bioplus (CEO Chung Hyun-kyu) signed a contract with Ora Bio (CEO Lee Hae-jin) on investment and joint management to enter the Botox business area.

Through this contract, it is expected to serve as a bridgehead for the development of next-generation Botox as well as joint management of Botox.

 

bioplubiz

Author bioplubiz

More posts by bioplubiz

Leave a Reply